CCXI insider filings
Churchill Capital Corp XI — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-04. Screen CCXI transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Klein Michael Stuart — See Remarks, Director, 10% owner & CHURCHILL SPONSOR XI LLC — 10% owner & M. Klein Associates, Inc. — 10% owner | 1 | — | — | 3 |
Recent insider filings — Churchill Capital Corp XI
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-04 | 4 | Klein Michael Stuart — See Remarks, Director, 10% owner CHURCHILL SPONSOR XI LLC — 10% owner M. Klein Associates, Inc. — 10% owner | Conversion (C): 14,525,000 · Conversion (C): 13,800,000 (derivative) · Other (J): 72,500 (derivative) | EDGAR |
| 2022-10-24 | 4 | Jain Rita — EVP, Chief Medical Officer, Director | Disposition to issuer (D): 35,863 · Disposition to issuer (D): 307 (derivative) · Disposition to issuer (D): 14,393 (derivative) · Disposition to issuer (D): 21,052 (derivative) · Disposition to issuer (D): 23,948 (derivative) · Disposition to issuer (D): 4,504 (derivative) · +2 more | EDGAR |
| 2022-10-24 | 4 | Herron Jennifer Lyn — Director | Disposition to issuer (D): 17,237 | EDGAR |
| 2022-10-24 | 4 | Edwards Thomas A. — Director | Disposition to issuer (D): 143,306 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · Disposition to issuer (D): 13,352 (derivative) · Disposition to issuer (D): 15,723 (derivative) | EDGAR |
| 2022-10-24 | 4 | Parker Geoffrey M. — Director | Disposition to issuer (D): 107,997 · Disposition to issuer (D): 21,076 · Disposition to issuer (D): 5,000 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · +3 more | EDGAR |
| 2022-10-24 | 4 | Schall Thomas J. — President and CEO, Director | Disposition to issuer (D): 2,393,352 · Disposition to issuer (D): 4,192 (derivative) · Disposition to issuer (D): 188,408 (derivative) · Disposition to issuer (D): 2,502 (derivative) · Disposition to issuer (D): 68,998 (derivative) · Disposition to issuer (D): 7,912 (derivative) · +14 more | EDGAR |
| 2022-10-24 | 4 | Cappel Markus J. — Chief Bus. Officer & Treasurer | Disposition to issuer (D): 87,658 · Disposition to issuer (D): 3,801 (derivative) · Disposition to issuer (D): 47,599 (derivative) · Disposition to issuer (D): 13,963 (derivative) · Disposition to issuer (D): 2,137 (derivative) · Disposition to issuer (D): 33,197 (derivative) · +7 more | EDGAR |
| 2022-10-24 | 4 | Wheadon David E. — Director | Disposition to issuer (D): 22,274 (derivative) | EDGAR |
| 2022-10-24 | 4 | Butt Tausif — EVP, Chief Operating Officer | Disposition to issuer (D): 10,870 · Disposition to issuer (D): 51,112 (derivative) · Disposition to issuer (D): 1,088 (derivative) · Disposition to issuer (D): 75,000 (derivative) · Disposition to issuer (D): 41,400 (derivative) | EDGAR |
| 2022-10-24 | 4 | Tyree James L — Director | Disposition to issuer (D): 9,138 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · Disposition to issuer (D): 13,352 (derivative) · Disposition to issuer (D): 12,500 (derivative) · +1 more | EDGAR |
| 2022-10-24 | 4 | FECZKO JOSEPH M — Director | Disposition to issuer (D): 148,127 · Disposition to issuer (D): 8,342 (derivative) · Disposition to issuer (D): 4,504 (derivative) · Disposition to issuer (D): 12,287 (derivative) · Disposition to issuer (D): 13,352 (derivative) · Disposition to issuer (D): 12,500 (derivative) · +1 more | EDGAR |
| 2022-10-24 | 4 | KANAYA SUSAN M — See Remarks, Director | Disposition to issuer (D): 91,317 · Disposition to issuer (D): 132,717 · Disposition to issuer (D): 71,280 (derivative) · Disposition to issuer (D): 3,920 (derivative) · Disposition to issuer (D): 2,198 (derivative) · Disposition to issuer (D): 19,202 (derivative) · +11 more | EDGAR |
| 2022-08-18 | 4 | KANAYA SUSAN M — EVP, CFO and Sec., Director | Option exercise (M): 19,898 @ $10.86 · Sale (S): 19,898 @ $50.95 · Option exercise (M): 19,898 (derivative) | EDGAR |
| 2022-08-08 | 4 | Schall Thomas J. — President and CEO, Director | Option exercise (M): 130,000 @ $14.28 · Sale (S): 130,000 @ $50.24 · Option exercise (M): 130,000 (derivative) | EDGAR |
| 2022-08-08 | 4 | Cappel Markus J. — Chief Bus. Officer & Treasurer | Sale (S): 7,564 @ $50.22 | EDGAR |
| 2022-08-08 | 4 | Tyree James L — Director | Sale (S): 10,000 @ $50.22 | EDGAR |
| 2022-08-08 | 4 | KANAYA SUSAN M — EVP, CFO and Sec., Director | Option exercise (M): 14,583 @ $6.23 · Option exercise (M): 31,715 @ $6.62 · Sale (S): 46,298 @ $50.17 · Option exercise (M): 14,583 (derivative) · Option exercise (M): 31,715 (derivative) | EDGAR |
| 2022-06-30 | 4 | Herron Jennifer Lyn — Director | Grant/award (A): 17,237 @ $0 | EDGAR |
| 2022-06-13 | 4 | Tyree James L — Director | Sale (S): 3,804 @ $25.65 · Sale (S): 59 @ $26.22 | EDGAR |
| 2022-06-08 | 4 | YAU YI CHING — SVP, Finance & Acctg Officer | Grant/award (A): 65,000 (derivative) | EDGAR |
| 2022-05-31 | 4 | Wheadon David E. — Director | Grant/award (A): 22,274 (derivative) | EDGAR |
| 2022-05-31 | 4 | Parker Geoffrey M. — Director | Grant/award (A): 15,723 (derivative) · Grant/award (A): 8,342 (derivative) | EDGAR |
| 2022-05-31 | 4 | Edwards Thomas A. — Director | Grant/award (A): 15,723 @ $0 · Grant/award (A): 8,342 (derivative) | EDGAR |
| 2022-05-31 | 4 | Tyree James L — Director | Grant/award (A): 15,723 (derivative) · Grant/award (A): 8,342 (derivative) | EDGAR |
| 2022-05-31 | 4 | FECZKO JOSEPH M — Director | Grant/award (A): 15,723 (derivative) · Grant/award (A): 8,342 (derivative) | EDGAR |
| 2022-05-24 | 4 | Parker Geoffrey M. — Director | Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative) | EDGAR |
| 2022-05-24 | 4 | Jain Rita — EVP, Chief Medical Officer, Director | Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative) | EDGAR |
| 2022-05-24 | 4 | Tyree James L — Director | Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative) | EDGAR |
| 2022-05-24 | 4 | MCKINNELL HENRY A — Director | Option exercise (M): 7,726 @ $0 · Option exercise (M): 7,726 (derivative) | EDGAR |
| 2022-05-03 | 4 | Parker Geoffrey M. — Director | Option exercise (M): 12,500 @ $14.42 · Option exercise (M): 12,500 (derivative) | EDGAR |
| 2022-03-29 | 4 | Jain Rita — EVP, Chief Medical Officer, Director | Option exercise (M): 5,251 @ $0 · Option exercise (M): 5,251 (derivative) | EDGAR |
| 2022-02-25 | 4 | Schall Thomas J. — President and CEO, Director | Grant/award (A): 152,700 (derivative) · Grant/award (A): 192,600 (derivative) | EDGAR |
| 2022-02-24 | 4 | Butt Tausif — EVP, Chief Operating Officer | Grant/award (A): 41,400 (derivative) · Grant/award (A): 52,200 (derivative) | EDGAR |
| 2022-02-24 | 4 | Jain Rita — EVP, Chief Medical Officer, Director | Grant/award (A): 11,600 (derivative) · Grant/award (A): 14,700 (derivative) | EDGAR |
| 2022-02-24 | 4 | Cappel Markus J. — Chief Bus. Officer & Treasurer | Grant/award (A): 40,700 (derivative) · Grant/award (A): 51,400 (derivative) | EDGAR |
| 2022-02-24 | 4 | KANAYA SUSAN M — EVP, CFO and Sec., Director | Grant/award (A): 59,700 (derivative) · Grant/award (A): 75,200 (derivative) | EDGAR |
| 2022-01-25 | 4 | FECZKO JOSEPH M — Director | Option exercise (M): 25,000 @ $15.90 · Option exercise (M): 12,500 @ $14.42 · Option exercise (M): 25,000 (derivative) · Option exercise (M): 12,500 (derivative) | EDGAR |
| 2022-01-04 | 4 | Schall Thomas J. — President and CEO, Director | Option exercise (M): 23,334 @ $0 · Option exercise (M): 34,567 @ $0 · Option exercise (M): 26,333 @ $0 · Tax withholding (F): 45,698 @ $36.41 · Option exercise (M): 23,334 (derivative) · Option exercise (M): 34,567 (derivative) · +1 more | EDGAR |
| 2022-01-04 | 4 | Cappel Markus J. — Chief Bus. Officer & Treasurer | Option exercise (M): 6,667 @ $0 · Option exercise (M): 7,767 @ $0 · Option exercise (M): 6,500 @ $0 · Tax withholding (F): 11,538 @ $36.41 · Option exercise (M): 6,667 (derivative) · Option exercise (M): 7,767 (derivative) · +1 more | EDGAR |
| 2022-01-04 | 4 | KANAYA SUSAN M — EVP, CFO and Sec., Director | Option exercise (M): 10,000 @ $0 · Option exercise (M): 10,333 @ $0 · Option exercise (M): 10,466 @ $0 · Tax withholding (F): 16,847 @ $36.41 · Option exercise (M): 10,000 (derivative) · Option exercise (M): 10,333 (derivative) · +1 more | EDGAR |
| 2021-12-21 | 4 | Tyree James L — Director | Option exercise (M): 25,000 @ $12.62 · Option exercise (M): 12,500 @ $14.42 · Sale (S): 2,800 @ $33.52 · Sale (S): 16,634 @ $34.74 · Sale (S): 18,066 @ $35.50 · Option exercise (M): 25,000 (derivative) · +1 more | EDGAR |
| 2021-12-03 | 4 | Schall Thomas J. — President and CEO, Director | Option exercise (M): 38,948 @ $10.27 · Option exercise (M): 6,988 @ $14.31 · Option exercise (M): 38,948 (derivative) · Option exercise (M): 6,988 (derivative) | EDGAR |
| 2021-10-13 | 4 | Vifor (International) Ltd — 10% owner Vifor Pharma Ltd. — 10% owner Vifor Fresenius Medical Care Renal Pharma Ltd. — 10% owner | Sale (S): 4,000,000 @ $39.43 | EDGAR |
| 2021-10-07 | 4 | Jain Rita — EVP, Chief Medical Officer, Director | Grant/award (A): 45,000 (derivative) | EDGAR |
| 2021-06-16 | 4 | Butt Tausif — EVP, Chief Operating Officer | Grant/award (A): 75,000 (derivative) | EDGAR |
| 2021-05-24 | 4 | Jain Rita — Director | Option exercise (M): 4,660 @ $0 · Grant/award (A): 7,726 (derivative) · Grant/award (A): 4,504 (derivative) · Option exercise (M): 4,660 (derivative) | EDGAR |
| 2021-05-24 | 4 | Edwards Thomas A. — Director | Grant/award (A): 7,726 @ $0 · Grant/award (A): 4,504 (derivative) | EDGAR |
| 2021-05-24 | 4 | Tyree James L — Director | Option exercise (M): 4,660 @ $0 · Sale (S): 2,454 @ $9.76 · Grant/award (A): 7,726 (derivative) · Grant/award (A): 4,504 (derivative) · Option exercise (M): 4,660 (derivative) | EDGAR |
| 2021-05-24 | 4 | FECZKO JOSEPH M — Director | Grant/award (A): 7,726 @ $0 · Grant/award (A): 4,504 (derivative) | EDGAR |
| 2021-05-24 | 4 | MCKINNELL HENRY A — Director | Grant/award (A): 7,726 (derivative) · Grant/award (A): 4,504 (derivative) | EDGAR |
Recent 8-K events — Churchill Capital Corp XI
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-13 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 4.01 — Changes in Registrant's Certifying Accountant 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics 5.06 — Change in Shell Company Status 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-11-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-30 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Registration filings — Churchill Capital Corp XI
Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.
- SEC file 333-299962 (S-1) — latest: Amendment (S-1/A), filed 2026-11-16
- SEC file 333-299960 (S-1) — latest: Amendment (S-1/A), filed 2026-11-16
GET https://api.filingpulse.io/v1/insider-trades?ticker=CCXI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs